ZA200903160B - Sulfonyl-Phenyl-2H-[1,2,4]Oxodiazol-5-one Derivatives, Processes for their preparation and their use as pharmaceuticals - Google Patents

Sulfonyl-Phenyl-2H-[1,2,4]Oxodiazol-5-one Derivatives, Processes for their preparation and their use as pharmaceuticals

Info

Publication number: ZA200903160B
Authority: ZA; South Africa
Prior art keywords: oxodiazol; pharmaceuticals; sulfonyl; phenyl; derivatives
Prior art date: 2006-12-14

Application number

ZA200903160A

Other languages

English (en)

Inventor

Stefanie Keil

Matthias Urmann

Karl Schoenafinger

Wolfgang Wendler

Maike Glien

Hans-Ludwig Schaefer

Eugen Falk

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-14

Filing date

2009-05-07

Publication date

2010-10-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37998695&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200903160(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-05-07 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2010-10-27 Publication of ZA200903160B publication Critical patent/ZA200903160B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Oncology (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Psychology (AREA)
Psychiatry (AREA)
Toxicology (AREA)
Urology & Nephrology (AREA)

ZA200903160A 2006-12-14 2009-05-07 Sulfonyl-Phenyl-2H-[1,2,4]Oxodiazol-5-one Derivatives, Processes for their preparation and their use as pharmaceuticals ZA200903160B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP06025880A EP1932843A1 (fr)	2006-12-14	2006-12-14	Dérivés de sulfonyl-phenyl-2H(1,2,4) oxadiazole-5-one, procédés de préparation de ceux-ci et leur usage sous forme de médicaments

Publications (1)

Publication Number	Publication Date
ZA200903160B true ZA200903160B (en)	2010-10-27

Family

ID=37998695

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200903160A ZA200903160B (en)	2006-12-14	2009-05-07	Sulfonyl-Phenyl-2H-[1,2,4]Oxodiazol-5-one Derivatives, Processes for their preparation and their use as pharmaceuticals

Country Status (24)

Country	Link
US (1)	US8173674B2 (fr)
EP (2)	EP1932843A1 (fr)
JP (1)	JP2010512352A (fr)
KR (1)	KR20090087922A (fr)
CN (1)	CN101558064A (fr)
AR (1)	AR064299A1 (fr)
AU (1)	AU2007331805A1 (fr)
BR (1)	BRPI0720416A2 (fr)
CA (1)	CA2672347A1 (fr)
CL (1)	CL2007003614A1 (fr)
CO (1)	CO6210729A2 (fr)
CR (1)	CR10778A (fr)
EC (1)	ECSP099409A (fr)
MA (1)	MA30981B1 (fr)
MX (1)	MX2009005535A (fr)
NO (1)	NO20092293L (fr)
PE (1)	PE20081404A1 (fr)
RU (1)	RU2009126745A (fr)
SV (1)	SV2009003293A (fr)
TN (1)	TN2009000242A1 (fr)
TW (1)	TW200843749A (fr)
UY (1)	UY30783A1 (fr)
WO (1)	WO2008071311A1 (fr)
ZA (1)	ZA200903160B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2010154279A (ru) *	2008-06-09	2012-07-20	Санофи-Авентис (Fr)	Аннелированные n-гетероциклические сульфонамиды с оксадиазолоновой концевой группой, способы их получения и их применение в качестве фармацевтических препаратов
WO2010000353A1 (fr) *	2008-06-09	2010-01-07	Sanofi-Aventis	Sulfonamides comprenant un hétérocycle et un groupe de tête oxadiazolone, procédés pour les préparer et leur utilisation comme produits pharmaceutiques
WO2011107494A1 (fr)	2010-03-03	2011-09-09	Sanofi	Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
US8933024B2 (en)	2010-06-18	2015-01-13	Sanofi	Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en)	2010-06-21	2013-09-10	Sanofi	Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en)	2010-07-05	2012-04-16	Sanofi Aventis	Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en)	2010-07-05	2012-06-01	Sanofi Sa	Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en)	2010-07-05	2012-04-16	Sanofi Sa	(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2013037390A1 (fr)	2011-09-12	2013-03-21	Sanofi	Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
WO2013045413A1 (fr)	2011-09-27	2013-04-04	Sanofi	Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b] pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
US8859774B2 (en)	2012-05-25	2014-10-14	Corcept Therapeutics, Inc.	Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
US12226412B2 (en)	2012-05-25	2025-02-18	Corcept Therapeutics, Inc.	Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
EP3851107B1 (fr) *	2012-05-25	2022-10-19	Corcept Therapeutics Incorporated	Modulateurs du récepteur des glucocorticoïdes d'azadécaline fusionné d'hétéroaryl de cétone
EP3371177A1 (fr)	2015-11-02	2018-09-12	Basf Se	Utilisation d'oxadiazoles substitués pour lutter contre les champignons phytopathogènes
EP3165094A1 (fr)	2015-11-03	2017-05-10	Basf Se	Oxadiazoles substitués pour lutter contre les champignons phytopathogènes
WO2017076740A1 (fr)	2015-11-04	2017-05-11	Basf Se	Utilisation d'oxadiazoles substitués pour lutter contre les champignons phytopathogènes
KR20180083417A (ko)	2015-11-19	2018-07-20	바스프 에스이	식물병원성 진균을 퇴치하기 위한 치환 옥사디아졸
WO2017085100A1 (fr)	2015-11-19	2017-05-26	Basf Se	Oxadiazoles substitués pour lutter contre des champignons phytopathogènes
BR112018069897B1 (pt)	2016-04-11	2023-01-17	Basf Se	Composto de fórmula i, composição agroquímica, processo para a preparação de compostos de fórmula i, uso não terapêutico de compostos e método para o combate de fungos fitopatogênicos nocivos
BR112018074559A2 (pt)	2016-06-09	2019-03-12	Basf Se	compostos, composição agroquímica, uso de compostos e método para combater fungos nocivos fitopatogênicos
EP3468959A1 (fr)	2016-06-09	2019-04-17	Basf Se	Oxadiazoles substitués pour lutter contre des champignons phytopathogènes
WO2018114393A1 (fr)	2016-12-19	2018-06-28	Basf Se	Oxadiazoles substitués pour lutter contre des champignons phytopathogènes
EP3339297A1 (fr)	2016-12-20	2018-06-27	Basf Se	Oxadiazoles substitués pour lutter contre les champignons phytopathogènes
PT3600282T (pt)	2017-03-31	2025-11-05	Corcept Therapeutics Inc	Moduladores de recetores de glucocorticoides para tratar cancro cervical
WO2018219797A1 (fr)	2017-06-02	2018-12-06	Basf Se	Oxadiazoles substitués utilisés pour lutter contre des champignons phytopathogènes
EP3642187A1 (fr)	2017-06-19	2020-04-29	Basf Se	2-[[5-(trifluorométhyl)-1,2,4-oxadiazol-3-yl]aryloxy](thio)acétamides pour lutter contre des champignons phytopathogènes
WO2019002158A1 (fr)	2017-06-30	2019-01-03	Basf Se	Trifluorométhyloxadiazoles substitués utilisés pour lutter contre des champignons phytopathogènes
WO2019052932A1 (fr)	2017-09-18	2019-03-21	Basf Se	Trifluorométhyloxadiazoles substitués permettant de lutter contre des champignons phytopathogènes
US11147275B2 (en)	2017-11-23	2021-10-19	Basf Se	Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi
US11464764B2 (en)	2018-12-19	2022-10-11	Corcept Therapeutics Incorporated	Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
WO2020132046A1 (fr)	2018-12-19	2020-06-25	Corcept Therapeutics Incorporated	Méthodes de traitement du cancer comprenant l'administration d'un modulateur du récepteur des glucocorticoïdes et d'un agent chimiothérapeutique anticancéreux
US11234971B2 (en)	2018-12-19	2022-02-01	Corcept Therapeutics Incorporated	Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
CN113490496A (zh)	2019-02-22	2021-10-08	科赛普特治疗学股份有限公司	一种杂芳基-酮稠合氮杂萘烷糖皮质激素受体调节剂瑞拉可兰的治疗用途
CN115361866B (zh) *	2020-03-31	2025-07-18	株式会社Lg化学	用于保护胰岛移植的组合物
WO2022134033A1 (fr)	2020-12-25	2022-06-30	Corcept Therapeutics Incorporated	Procédés de préparation de modulateurs du récepteur des glucocorticoïdes d'azadécaline fusionnée hétéroaryle-cétone
WO2024077169A1 (fr)	2022-10-06	2024-04-11	Corcept Therapeutics Incorporated	Formulations de modulateurs des récepteurs des glucocorticoïdes
EP4608402A1 (fr)	2022-10-28	2025-09-03	Corcept Therapeutics Incorporated	Traitements de la sclérose latérale amyotrophique à l'aide de dazucorilant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5641796A (en) *	1994-11-01	1997-06-24	Eli Lilly And Company	Oral hypoglycemic agents
DE10222034A1 (de) *	2002-05-17	2003-11-27	Bayer Ag	Tetrahydroisochinolin-Derivate
DE10229777A1 (de) *	2002-07-03	2004-01-29	Bayer Ag	Indolin-Phenylsulfonamid-Derivate
WO2004080943A1 (fr) *	2003-03-11	2004-09-23	Ono Pharmaceutical Co., Ltd.	Procede permettant d'ajouter du charbon actif dans la purification d'eau et procede de purification d'eau
WO2004092117A1 (fr)	2003-04-07	2004-10-28	Kalypsys, Inc.	Composes phenyle a substitution para-sulfonyle utilises en tant que modulateurs des ppar
DE10335449A1 (de)	2003-08-02	2005-02-17	Bayer Healthcare Ag	Bicyclische Indolinsulfonamid-Derivate
DE602004004631D1 (de) *	2004-04-01	2007-03-22	Sanofi Aventis Deutschland	Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika

2006
- 2006-12-14 EP EP06025880A patent/EP1932843A1/fr not_active Withdrawn
2007
- 2007-11-30 RU RU2009126745/04A patent/RU2009126745A/ru not_active Application Discontinuation
- 2007-11-30 MX MX2009005535A patent/MX2009005535A/es not_active Application Discontinuation
- 2007-11-30 WO PCT/EP2007/010390 patent/WO2008071311A1/fr not_active Ceased
- 2007-11-30 JP JP2009540626A patent/JP2010512352A/ja not_active Abandoned
- 2007-11-30 CA CA002672347A patent/CA2672347A1/fr not_active Abandoned
- 2007-11-30 CN CNA2007800454445A patent/CN101558064A/zh active Pending
- 2007-11-30 AU AU2007331805A patent/AU2007331805A1/en not_active Abandoned
- 2007-11-30 KR KR1020097012309A patent/KR20090087922A/ko not_active Withdrawn
- 2007-11-30 BR BRPI0720416-7A patent/BRPI0720416A2/pt not_active IP Right Cessation
- 2007-11-30 EP EP07846915.2A patent/EP2102198B1/fr active Active
- 2007-12-12 CL CL200703614A patent/CL2007003614A1/es unknown
- 2007-12-12 PE PE2007001772A patent/PE20081404A1/es not_active Application Discontinuation
- 2007-12-12 TW TW096147333A patent/TW200843749A/zh unknown
- 2007-12-12 UY UY30783A patent/UY30783A1/es not_active Application Discontinuation
- 2007-12-12 AR ARP070105563A patent/AR064299A1/es not_active Application Discontinuation
2009
- 2009-05-07 CR CR10778A patent/CR10778A/es not_active Application Discontinuation
- 2009-05-07 ZA ZA200903160A patent/ZA200903160B/xx unknown
- 2009-06-05 CO CO09058528A patent/CO6210729A2/es not_active Application Discontinuation
- 2009-06-09 US US12/480,974 patent/US8173674B2/en not_active Expired - Fee Related
- 2009-06-10 SV SV2009003293A patent/SV2009003293A/es unknown
- 2009-06-10 MA MA31971A patent/MA30981B1/fr unknown
- 2009-06-12 TN TNP2009000242A patent/TN2009000242A1/fr unknown
- 2009-06-12 EC EC2009009409A patent/ECSP099409A/es unknown
- 2009-06-15 NO NO20092293A patent/NO20092293L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP2102198B1 (fr)	2015-02-25
CO6210729A2 (es)	2010-10-20
TN2009000242A1 (en)	2010-10-18
EP2102198A1 (fr)	2009-09-23
CA2672347A1 (fr)	2008-06-19
EP1932843A1 (fr)	2008-06-18
CN101558064A (zh)	2009-10-14
CL2007003614A1 (es)	2008-06-20
WO2008071311A1 (fr)	2008-06-19
TW200843749A (en)	2008-11-16
US20090298871A1 (en)	2009-12-03
AR064299A1 (es)	2009-03-25
AU2007331805A1 (en)	2008-06-19
RU2009126745A (ru)	2011-01-20
SV2009003293A (es)	2009-10-27
CR10778A (es)	2009-06-24
NO20092293L (no)	2009-09-08
KR20090087922A (ko)	2009-08-18
MA30981B1 (fr)	2009-12-01
BRPI0720416A2 (pt)	2013-12-31
MX2009005535A (es)	2009-06-05
UY30783A1 (es)	2008-07-31
US8173674B2 (en)	2012-05-08
PE20081404A1 (es)	2008-11-04
ECSP099409A (es)	2009-07-31
JP2010512352A (ja)	2010-04-22

Publication	Publication Date	Title
ZA200903160B (en)	2010-10-27	Sulfonyl-Phenyl-2H-[1,2,4]Oxodiazol-5-one Derivatives, Processes for their preparation and their use as pharmaceuticals
SI1931660T1 (sl)	2012-12-31	Derivati fenil-(1,2,4)-oksadiazol-5-ona s fenilno skupino, postopki za njihovo pripravo in njihova uporaba kot zdravila
ZA200805939B (en)	2009-12-30	Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL190231A0 (en)	2008-11-03	Phenyl-and pyridinyl-1,2,4-oxadiazolone derivatives processes for their preparation and their use as pharmaceuticals
IL194835A (en)	2015-04-30	History of cyclohexylpyrazole-lactam, an intermediate substance for their use in the preparation of drugs
IL193772A0 (en)	2009-08-03	4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
IL192845A (en)	2013-04-30	The history of benzamide and the trower, a process for making them and their pharmaceutical preparations
IL206395A (en)	2015-04-30	N- Heterocyclic-7-Oxo-6-Sulphoxy-6,1-Diazabicyclo [1.2.3] Octane-2-Carboxamides and Pharmaceuticals Containing Them
IL187235A0 (en)	2008-02-09	2,6 quinolinyl derivatives, processes for preparing them and their use as medicament
IL192009A0 (en)	2008-12-29	Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
EP2157093A4 (fr)	2012-03-07	Dérivés pyrrolo-azotés hétérocycliques, leur préparation et leur utilisation pharmaceutique
ZA200901268B (en)	2010-04-28	Substituted imidazolone derivatives, preparation and uses
IL206808A (en)	2015-08-31	Indolyl-pyridone history, their pharmaceutical preparations and their uses
IL193341A0 (en)	2009-05-04	Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
IL193339A0 (en)	2009-05-04	Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL196136A (en)	2014-11-30	Its aminoindane or salt derivative, the pharmaceutical composition containing them and their uses
IL190460A0 (en)	2008-11-03	4-oxy-n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
IL193155A0 (en)	2009-02-11	Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
EP2025667A4 (fr)	2012-08-29	Dérivé de 9,10-sécoprégnane et produit pharmaceutique
TWI315305B (en)	2009-10-01	Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof
PL1988090T3 (pl)	2013-10-31	Pochodne kwasu imidazolo-5-karboksylowego, sposoby przygotowania i ich zastosowanie
PT2231598E (pt)	2011-10-11	Novos derivados diazéniodiolato, processo para a sua preparação e as composições farmacêuticas que os contenham
IL190596A0 (en)	2008-11-03	9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
IL193384A0 (en)	2009-05-04	Substituted prolinamides, their preparation and their use as pharmaceuticals
HUP0500921A2 (en)	2007-07-30	Tetrazole derivatives, process for their preparation and their use